FDA Inspection 596173 — DAPIN GmbH
The FDA completed an inspection of DAPIN GmbH on June 25, 2009 in Halle (Westf.). The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 25, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Halle (Westf.) (Germany)